These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 169121)

  • 21. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
    Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
    J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative studies of receptor binding and steroidogenic properties of angiotensins in the rat adrenal glomerulosa.
    Douglas JG; Michailov M; Khosla MC; Bumpus FM
    Endocrinology; 1979 Jan; 104(1):71-5. PubMed ID: 446357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of DES-ASP1-angiotensin II is not an obligatory step in the steroidogenic action of angiotensin II in the canine adrenal.
    Douglas J; Bartley P; Kondo T; Catt K
    Endocrinology; 1978 Jun; 102(6):1921-4. PubMed ID: 744059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the adrenal angiotensin receptor angiotensin II--or angiotensin III like?
    Braley LM; Menachery AI; Underwood RH; Williams GH
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):116-21. PubMed ID: 6297210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
    Goghari MH; Franklin KJ; Moore GJ
    J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues.
    Bennett JP; Snyder SH
    Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
    Samanen J; Brandeis E; Narindray D; Adams W; Cash T; Yellin T; Regoli D
    J Med Chem; 1988 Apr; 31(4):737-41. PubMed ID: 3351849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the binding of [3H]L-158,809: a new potent and selective nonpeptide angiotensin II receptor (AT1) antagonist radioligand.
    Chen TB; Lotti VJ; Chang RS
    Mol Pharmacol; 1992 Dec; 42(6):1077-82. PubMed ID: 1480133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade.
    Matsoukas J; Cordopatis P; Belte U; Goghari MH; Ganter RC; Franklin KJ; Moore GJ
    J Med Chem; 1988 Jul; 31(7):1418-21. PubMed ID: 2455051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II receptors and aldosterone production in rat adrenal glomerulosa cells.
    Douglas J; Aguilera G; Kondo T; Catt K
    Endocrinology; 1978 Mar; 102(3):685-96. PubMed ID: 217598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The additivity principle in the reaction of angiotensin II and its analogs with antibodies and receptors of glomerular cells from the rat adrenal cortex].
    Zalitis GM; Kublis GG; Antsans IuE
    Biokhimiia; 1985 Jul; 50(7):1083-9. PubMed ID: 2994760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pressor and stereoidogenic actions of [des-Asp1]angiotensin I dependency on conversion to angiotensin III.
    Vaughan ED; Peach MJ; Ackerly JA; Tsai BS; Larner A
    Circ Res; 1977 May; 40(5 Suppl 1):I94-7. PubMed ID: 858177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of angiotensin receptors on bovine adrenal fasciculata cells.
    Vallotton MB; Capponi AM; Grillet C; Knupfer AL; Hepp R; Khosla MC; Bumpus FM
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):592-6. PubMed ID: 6264451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
    Moore GJ; Ganter RC; Goghari MH; Franklin KJ
    Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms and sites of action of newer angiotensin agonists and antagonists in terms of activity and receptor.
    Bumpus FM
    Fed Proc; 1977 Jul; 36(8):2128-32. PubMed ID: 194800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that des-Asp1 angiotensin II mediates the renin-angiotensin response.
    Freeman RH; Davis JO; Lohmeier TE; Spielman WS
    Circ Res; 1976 Jun; 38(6 Suppl 2):99-103. PubMed ID: 178468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of two different angiotensin II antagonists on aldosterone secretion by isolated perfused rat zona glomerulosa cells.
    Boscaro M; Al-Dujaili EA; Edwards CR
    Endocrinology; 1981 Jun; 108(6):2381-4. PubMed ID: 6262059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies defining minimal receptor domains for angiotensin II.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1989 Jul; 250(1):31-6. PubMed ID: 2746504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical characterization of photoaffinity-labeled angiotensin II receptors.
    Carson MC; Harper CM; Baukal AJ; Aguilera G; Catt KJ
    Mol Endocrinol; 1987 Feb; 1(2):147-53. PubMed ID: 3137454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.